Sr. Communications Manager
Society for Clinical Research Sites
FOR IMMEDIATE RELEASE
Ellicott City, MD, October 15, 2018 – The Society for Clinical Research Sites (SCRS) announced to almost 1,000 attendees at their 2018 Global Site Solutions Summit that AstraZeneca is the winning sponsor, and Syneos Health (formerly INC Research/inVentiv Health) is the winning CRO of the 2018 SCRS Eagle Award.
Sponsored by Trifecta Clinical, the SCRS Eagle Award has been awarded annually since 2009 to recognize the sponsor and CRO that are most dedicated to outstanding leadership, professionalism, integrity, operational excellence and a commitment to advancing the clinical research profession through strong site partnerships. SCRS members determine the nominees, and winners are voted on by SCRS member and non-member sites.
“Winning the Eagle Award reflects a dedication and commitment to outstanding working relationships with sites,” said SCRS president Christine Pierre. “Congratulations to AstraZeneca and Syneos Health for succeeding in raising industry standards to establish strong site partnerships.”
In addition to AstraZeneca, this year’s sponsor finalists for the Eagle Award were Eli Lilly & Co., Merck, Novo Nordisk and Pfizer.
Joining Syneos Health, this year’s CRO Eagle Award finalists were ICON and IQVIA.
The 2019 Global Site Solutions Summit will be held October 11-13, 2019 at The Diplomat Beach Resort in Hollywood, Florida.
Founded in 2012, SCRS is the trade organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, connectivity and mentorship. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit MySCRS.org.